apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo (2021) Mahdikia H, Saadati F, Freund E, Gaipl U, Majidzadeh-a K, Shokri B, Bekeschus S Journal article Radon exposure—therapeutic effect and cancer risk (2021) Maier A, Wiedemann J, Rapp F, Papenfuß F, Rödel F, Hehlgans S, Gaipl U, et al. Journal article, Review article Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis (2020) Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, et al. Journal article Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Milic M, Carre A, et al. Conference contribution Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution Identification of nine lncRNAs signature for predicting survival benefit of melanoma patients treated with immune checkpoint inhibitors (2020) Zhou JG, Ma H, Gaipl U Conference contribution Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Rouyar A, Milic M, et al. Journal article Defining metaniches in the oral cavity according to their microbial composition and cytokine profile (2020) Seidel CL, Gerlach R, Wiedemann P, Weider M, Rodrian G, Hader M, Frey B, et al. Journal article Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article